Diasorin reported EUR101M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Amplifon EUR 449.68M 691.38M Mar/2026
Avanos Medical USD 88M 6.9M Mar/2026
Brookdale Senior Living USD 548.5M 94.81M Mar/2026
Cencora USD 75.02B 8.1B Mar/2026
Diasorin EUR 101M 7.58M Mar/2026
Encompass Health USD 151.6M 700K Mar/2026
Enovis USD 265.57M 5.95M Mar/2026
GE HealthCare Technologies USD 3.15B 283M Mar/2026
OPKO Health USD 78.44M 25.04M Mar/2026
Veradigm USD 124.74M 56.25M Dec/2022
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026